Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

IRIN Examines PEPFAR Funding Of IDU Programs
IRIN examines a recent comment piece in the journal Lancet that argues PEPFAR can do more to prevent the spread of HIV among injecting drug users (IDUs) in Africa (IRIN, 6/24). Although PEPFAR has helped to provide "antiretroviral therapy to 2.1 million people with HIV, almost all of whom live in sub-Saharan Africa, and has spent more than $18 billion on the continent," it has failed to reach "thousands of injecting drug users in PEPFAR countries in Africa, many of whom have HIV," according to the authors of the Lancet article (Kaiser Global Health Policy Report, 6/19).

Growth Factor May Explain Why African-Americans Are At Greater Risk Of Hypertension And Kidney Disease
Physician-scientists from NewYork-Presbyterian Hospital/Weill Cornell Medical Center believe that a heightened level a certain growth factor in the blood may explain why blacks have a greater prevalence of hypertension and kidney disease compared to whites. Results from a new study are the first to show that an elevated level of a protein, called transforming growth factor B1 (TGF-B1), raises the risk of hypertension and renal disease in humans.
News of the day
United States FDA Clears The REGEN Trial To Test Bioheart's Combination Gene And Stem Cell Therapy In Heart Failure Patients
Bioheart, Inc., (OTC Bulletin Board: BHRT) a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular diseases announced today that the US FDA cleared a phase I clinical trial for MyoCell SDF-1 (Stromal Derived Factor - 1) to treat congestive heart failure. The REGEN trial will enroll 15 patients in a multicenter, randomized, dose escalation study to assess the safety and cardiovascular effects of the implantation of MyoCell SDF-1 in congestive heart failure patients post myocardial infarction(s).
Health Insurance

Parent's Guide To Cord Blood Foundation Introduces New Brochure During Cord Blood Awareness Month To Address Critical Education Gap

Expectant parents are poorly informed about cord blood banking, according to a study published in the Journal of Reproductive Medicine. In fact, of the expectant mothers in the study who indicated they have some knowledge of cord blood banking, 74 percent considered themselves minimally informed. Yet, the Institute of Medicine of the National Academy of Sciences recommends that all expectant parents should be educated about cord blood stem cells early enough in pregnancy that they can make an informed decision about the options to preserve these medically-beneficial cells. To help address this significant education gap, Parent"s Guide to Cord Blood Foundation, the most comprehensive re for expectant parents about cord blood medical research and cord blood storage options, today announced the release of a new educational brochure for expectant parents in conjunction with Cord Blood Awareness Month. The brochure has been vetted and endorsed by a scientific and medical advisory board of leading caregivers and researchers and follows the guidance of the Institute of Medicine. "Cord blood stem cells are an increasingly important medical re for saving lives," said Frances Verter, Ph.D., founder of Parent"s Guide to Cord Blood Foundation. "This brochure is intended to ensure that more pregnant women have the opportunity to consider saving their newborn"s cord blood for family use or donating the cord blood to others who may have a critical medical need. I want all women to understand why cord blood should be preserved and why allowing these cells to be thrown away as medical waste should be a last choice option." Dr. Verter founded the Parent"s Guide to Cord Blood in 1998 after her daughter Shai died of leukemia. What started as a small community service, has grown to become one of the leading parent res on all aspects of cord blood banking. In 2007, the Parent"s Guide to Cord Blood Foundation incorporated as a non-profit organization, making all donations fully tax deductible. The release of the brochure expands the educational mission of the foundation beyond the Internet, into birthing classes and physician"s offices. To date, 16 states have passed laws to improve cord blood education during pregnancy, and to encourage physicians to take an active role in educating expectant parents about the options for banking cord blood. A federal bill sponsored by Representative Jackie Speier is currently under consideration in Congress. The brochure from the Parent"s Guide to Cord Blood Foundation was created to meet the educational requirements of these public policy initiatives and can be distributed by physicians and other healthcare providers. About Cord Blood The blood that remains in a newborn"s umbilical cord immediately following birth contains a diverse population of stem cells that have distinct characteristics and benefits compared to other s of stem cells. Since cord blood stem cells are immunologically younger than other "adult" stem cell s, they demonstrate more versatility and flexibility when used in transplantation. In addition, cord blood stem cells have demonstrated embryonic-like capabilities to proliferate and develop into all of the major cell types in the body. For more than 20 years, cord blood stem cells have been used in transplants to cure patients of cancers like leukemia and lymphoma, as well as blood diseases and immune disorders. Birth is the one-time opportunity when parents can either donate their child"s cord blood to a public bank, where it can be matched with patients seeking a transplant donor, or they can preserve it for their own family in a private bank. Yet only a few percent of parents in the U.S. take advantage of either option. About Cord Blood Awareness Month July has been designated "Cord Blood Awareness Month" by the American Hospital Association"s Society for Healthcare Strategy & Market Development (SHSMD) with the goal of raising awareness about newborn stem cells from umbilical cord blood. Cord Blood Awareness Month strives to empower expectant parents to make informed choices regarding their family"s future health. About Parent"s Guide to Cord Blood Foundation The mission of the Parent"s Guide to Cord Blood (PGCB) Foundation is to provide parents with impartial education about cord blood medical research and cord blood storage options, as well as to conduct and publish statistical analyses on medical research or policy developments which could expand the likelihood of cord blood usage. The PGCB Foundation is a 501 (c)(3) charitable educational organization which is supported by donations from individuals and organizations that support the Foundation"s mission. All donations are fully tax-deductible. Parent"s Guide to Cord Blood Foundation


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009